Breast cancer in males.

Q3 Nursing

Nursing Pub Date : 2025-03-01 Epub Date: 2025-02-21 DOI:10.1097/NSG.0000000000000146

Richard L Pullen

引用次数: 0

Abstract

Abstract: Male breast cancer (BC) is a rare but clinically significant disease, accounting for approximately 1% of all BC diagnoses. This article examines the unique risk factors, including genetic mutations (such as BRCA2), hormonal influences, and social determinants of health that contribute to the incidence of BC in males. In addition, this article highlights the need for improved awareness, targeted screening, and tailored treatment strategies to address the distinct challenges faced by male patients with BC.

查看原文本刊更多论文

男性乳腺癌。

摘要：男性乳腺癌（BC）是一种罕见但临床意义重大的疾病，约占所有 BC 诊断病例的 1%。本文探讨了导致男性乳腺癌发病的独特风险因素，包括基因突变（如 BRCA2）、荷尔蒙影响和健康的社会决定因素。此外，本文还强调了提高认识、针对性筛查和定制治疗策略的必要性，以应对男性 BC 患者所面临的独特挑战。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nursing Medicine-Medicine (all)

CiteScore

0.80

自引率

0.00%

发文量

338

期刊介绍： Nursing2020 (ISSN 0360-4039; online ISSN 1538-8689) published its first issue in November 1971, under founders Gene W. Jackson and Daniel Cheney. In the intervening years, its circulation has grown to over 150,000, making it one of the largest nursing journals in the world. Published monthly, Nursing2020 is widely regarded as offering current, practical contents to its readers, and has won many editorial awards testifying to the quality of its copy and graphics. The editorial and clinical staff, a 19-member Editorial Board of distinguished clinicians and practitioners, and over 100 invited reviewers help ensure the quality of this publication.